SCHEMBL10160294

SCHEMBL10160294

CCCc1ccc2c(c1)c1cc(N(c3ccccc3)c3ccc(-c4ccc5c(-c6ccccc6)c6ccccc6c(-c6ccccc6)c5c4)cc3)ccc1n2-c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4A P47712 1/20 0.35
TSPO P30536 2/20 0.35
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP1A2 P05177 1/20 0.33
GLA P06280 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
MAPK8 P45983 1/20 0.32
RORA P35398 1/20 0.31
RORC P51449 1/20 0.31
RORB Q92753 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
ATM Q13315 1/20 0.31
KMT2A Q03164 2/20 0.31
MCL1 Q07820 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10175858 0.96 TSPO (0.36) PLA2G4ATSPOKDM4EALDH1A1CYP1A2
SCHEMBL14029433 0.96 PLA2G4A (0.38) PLA2G4ATSPOKDM4EALDH1A1CYP1A2
SCHEMBL10161081 0.94 MAPK8 (0.38) PLA2G4ATSPOMAPK8RORARORC
SCHEMBL262076 0.94 TSPO (0.37) PLA2G4ATSPOKDM4EALDH1A1CYP1A2
SCHEMBL2613950 0.92 TSPO (0.36) PLA2G4ATSPOKDM4ERXRARXRB
SCHEMBL10175855 0.90 MAPK8 (0.39) PLA2G4ATSPOMAPK8RORARORC
SCHEMBL14029408 0.90 RORA (0.38) PLA2G4ATSPOMAPK8RORARORC
SCHEMBL2613578 0.89 L3MBTL1 (0.38) TSPOKDM4EALDH1A1L3MBTL1ATM
SCHEMBL10161126 0.89 L3MBTL1 (0.38) TSPOKDM4EALDH1A1L3MBTL1ATM
SCHEMBL14521315 0.89 RORA (0.39) PLA2G4ATSPOKDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288012-B2 Anthracene derivatives and light-emitting devices using the anthracene derivatives SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-16 US disclosed
US-8288012-B2 Anthracene derivatives and light-emitting devices using the anthracene derivatives SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-16 US disclosed
US-20120211728-A1 Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-08-23 US disclosed
US-20120211728-A1 Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-08-23 US disclosed
EP-2031036-B1 Light-emitting element, light-emitting device, and electronic appliance SEMICONDUCTOR ENERGY LAB (JP) 2012-06-27 EP disclosed
US-8101289-B2 Light-emitting element, light-emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-24 US disclosed
US-8101289-B2 Light-emitting element, light-emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-24 US disclosed
US-20090058278-A1 Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-03-05 US disclosed
US-20090058278-A1 Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-03-05 US disclosed
EP-2031036-A1 Light-emitting element, light-emitting device, and electronic appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-03-04 EP disclosed
US-20090004506-A1 Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-01-01 US disclosed
US-20090004506-A1 Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090004506-A1 Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives CRY1, CYP1A1, GLB1 PLA2G4A 1003/4885TSPO 2918/4885KDM4E 3561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.